WHO chief Tedros Adhanom Ghebreyesus said two candidate vaccines developed specifically for the Bundibugyo Ebola strain are expected to begin testing in the Democratic Republic of Congo as early as next week. The Tumaini trial will assess their safety, efficacy and ability to trigger an immune response, using ring vaccination for high-risk contacts.
1 report from 1 publisher confirmed as covering this specific event.
Reporting from 1 identified publisher for this event.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 92 of 22954
Same format. Every time.
Continue reading — sign in or create a free account with